Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70
(0.87%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy's Laboratories rises on launching Febuxostat Tablets in US Market
>>
Dr. Reddy's Laboratories launches Febuxostat Tablets in US Market
>>
Dr. Reddy's, RDIF commence clinical trials for Sputnik V vaccine in India
>>
Dr. Reddy’s Lab gains on entering into definitive agreement with Glenmark Pharmaceuticals
>>
Dr. Reddy’s enters into definitive agreement with Glenmark Pharmaceuticals
>>
Dr. Reddy’s rises on launching Succinylcholine Chloride Injection in US Market
>>
Dr. Reddy’s launches Succinylcholine Chloride Injection in US Market
>>
Reliance Industries, EPL and Dr. Reddy’s to see some action today
>>
Dr. Reddy's partners with BIRAC for Sputnik V vaccine clinical trials in India
>>
Dr. Reddy's Laboratories shines despite reporting 30% fall in Q2 consolidated net profit
<<
<
49
50
51
...145
>
>>